Glucoact 80 mg (Tablet)
Unit Price: ৳ 6.01 (3 x 10: ৳ 180.30)
Strip Price: ৳ 60.10
Medicine Details
Category | Details |
---|---|
Generic | Gliclazide |
Company | Veritas pharmaceuticals ltd |
Title
- Glucoact 80 mg Tablet
Categories
- Medicine
- Healthcare
- Diabetes Management
Description
- Oral antidiabetic medicine belonging to the sulphonylurea group
- Used in type 2 diabetes Mellitus in adults
- Stimulates the release of insulin from pancreatic cells
- Reduces hepatic glucose output
- Usual initial dose is 40 to 80 mg daily
- Maximum dose can be increased up to 320 mg daily
- Dosage may vary based on individual blood sugar levels
- Can be taken as a film-coated tablet or modified release preparation
- Interacts with other medicines such as high blood pressure medications, antibiotics, antifungal drugs, etc.
- Can cause side effects like low blood sugar, liver disorders, skin disorders, etc.
- Not recommended during pregnancy and lactation
- Requires proper storage and disposal to protect the environment
Dimensions
Color Options
Functions
- Reduces blood sugar levels
- Stimulates insulin release
- Decreases hepatic glucose output
Materials
Technical Specifications
- Molecular Formula: C15H21N3O3S
Design Elements
Usability Features
- Dosage tied to meals
- Requires regular monitoring of blood sugar levels
- Effects last for an average duration of 24 hours
- General instructions for intake and precautions
Dosage Instructions
- Usual initial dose is 40 to 80 mg daily
- Maximum dose can be increased up to 320 mg daily
- Dosage may vary based on individual blood sugar levels
- Take as a film-coated tablet or modified release preparation
- Consult doctor for combination therapy and dose adjustments
Dosage Administration
- To be taken before meals
- One to four tablets (maximum 120 mg) in a single intake at breakfast time
- Swallow whole tablet(s) with water
- Always eat a meal after taking the tablet(s)
- In case of overdose, seek immediate medical attention
- Do not take a double dose if a dose is missed
Interaction with Other Medicines
- Strengthens or weakens blood sugar lowering effect with certain medications
- Consult doctor before starting another medicinal product
- Inform medical staff about the intake of Glucoact in case of hospitalization
Contraindications
- Allergic to gliclazide or related medicines
- Insulin-dependent diabetes (type 1)
- Presence of ketone bodies and sugar in urine
- Severe kidney or liver disease
- Taking medicines to treat fungal infections
- Breastfeeding
Side Effects
- Low blood sugar (hypoglycaemia)
- Liver disorders
- Skin disorders
- Blood disorders
- Digestive disorders
- Eye disorders
- Reporting of side effects to doctor or pharmacist
Pregnancy & Lactation Warnings
- Not recommended during pregnancy
- Not to be taken while breastfeeding
Precautions & Warnings
- Strict adherence to treatment plan prescribed by doctor
- Regular monitoring of blood and urine sugar levels
- Increased risk of reduced blood sugar levels in the first few weeks of treatment
- Low blood sugar symptoms and management
- High blood sugar symptoms and management
- Importance of monitoring blood glucose when prescribed with specific antibiotics
- Consult doctor before use in case of glucose-6-phosphate dehydrogenase (G6PD) deficiency
Therapeutic Class
- Sulfonylureas
Storage Conditions
- Store below 30°C
- Keep out of the reach and sight of children
- Do not use after expiry date
- Dispose of via pharmacist
- Protect the environment
Chemical Structure
- Molecular Formula : C15H21N3O3S
Commonly Asked Questions
- General information about Glucoact
- Effects of intake without eating
- Missed dose instructions
- Duration of effect
- Pregnancy warnings
- General instructions for intake and precautions
Related Brands
- Admira 80 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Admira MR 30 mg (Tablet (Modified Release)) - unimed-unihealth-pharmaceuticals-ltd
- Comprid 80 mg (Tablet) - square-pharmaceuticals-plc
- Comprid XR 30 mg (Tablet (Extended Release)) - square-pharmaceuticals-plc
- Consucon 80 mg (Tablet) - incepta-pharmaceuticals-ltd